Eric Hatterer

969 total citations
23 papers, 659 citations indexed

About

Eric Hatterer is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Biomaterials. According to data from OpenAlex, Eric Hatterer has authored 23 papers receiving a total of 659 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 6 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Biomaterials. Recurrent topics in Eric Hatterer's work include Phagocytosis and Immune Regulation (7 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Nanoparticle-Based Drug Delivery (5 papers). Eric Hatterer is often cited by papers focused on Phagocytosis and Immune Regulation (7 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Nanoparticle-Based Drug Delivery (5 papers). Eric Hatterer collaborates with scholars based in Switzerland, France and United States. Eric Hatterer's co-authors include Serge Nataf, Marie‐Françoise Belin, Nathalie Davoust, Carine Vuaillat, Christophe Malcus, Marie Kosco‐Vilbois, M. Didier‐Bazes, Walter Ferlin, Limin Shang and Jérôme Honnorat and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Eric Hatterer

22 papers receiving 649 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eric Hatterer Switzerland	13	315	156	118	114	114	23	659
Ljiljana Križanac-Bengez United States	14	88 0.3×	326 2.1×	225 1.9×	86 0.8×	101 0.9×	22	891
Shinya Kida Japan	17	124 0.4×	169 1.1×	251 2.1×	36 0.3×	298 2.6×	45	933
Nathalie Koning Netherlands	12	517 1.6×	504 3.2×	225 1.9×	21 0.2×	91 0.8×	13	1.0k
Ulrike May Finland	13	187 0.6×	113 0.7×	175 1.5×	17 0.1×	35 0.3×	17	673
Jason Gibson United States	14	141 0.4×	63 0.4×	467 4.0×	74 0.6×	80 0.7×	22	1.1k
Bartosz Bielecki Poland	13	271 0.9×	188 1.2×	177 1.5×	15 0.1×	91 0.8×	16	758
Aline Dumas Canada	15	194 0.6×	87 0.6×	232 2.0×	19 0.2×	54 0.5×	19	556
Marco Calafiore United States	15	156 0.5×	58 0.4×	372 3.2×	28 0.2×	146 1.3×	25	826
Mariola Matysiak Poland	15	222 0.7×	166 1.1×	265 2.2×	16 0.1×	70 0.6×	34	825
Geraldine Flynn United Kingdom	17	254 0.8×	120 0.8×	414 3.5×	16 0.1×	114 1.0×	29	1.1k

Countries citing papers authored by Eric Hatterer

Since Specialization

Citations

This map shows the geographic impact of Eric Hatterer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Hatterer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Hatterer more than expected).

Fields of papers citing papers by Eric Hatterer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Hatterer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Hatterer. The network helps show where Eric Hatterer may publish in the future.

Co-authorship network of co-authors of Eric Hatterer

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Hatterer. A scholar is included among the top collaborators of Eric Hatterer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Hatterer. Eric Hatterer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhan, Xiaoni, Wen Li, Eric Hatterer, et al.. (2025). Strain-Distinct α-Synuclein and Tau Cross-Seeding Uncovered by Correlative Approach with Optical Photothermal Infrared Sub-Micron Imaging. Journal of the American Chemical Society. 147(31). 27323–27340. 1 indexed citations

Hatterer, Eric, Laurence Chatel, Bruno Daubeuf, et al.. (2025). Selective activation of interleukin-2/interleukin-15 receptor signaling in tumor microenvironment using paired bispecific antibodies. Journal for ImmunoTherapy of Cancer. 13(3). e010650–e010650.

Hatterer, Eric, Xavier Chauchet, Françoise Richard, et al.. (2020). Targeting a membrane-proximal epitope on mesothelin increases the tumoricidal activity of a bispecific antibody blocking CD47 on mesothelin-positive tumors. mAbs. 12(1). 1739408–1739408. 33 indexed citations

Moine, Valéry, Xavier Chauchet, Lucile Broyer, et al.. (2019). Abstract A088: Selective blockage of the innate immune checkpoint receptor CD47 on mesothelin (MSLN) positive solid tumor cells via dual targeting bispecific antibodies alters the tumor microenvironment to control tumor growth. Cancer Immunology Research. 7(2_Supplement). A088–A088. 1 indexed citations

Shang, Limin, Vanessa Buatois, Eric Hatterer, et al.. (2019). Abstract 546: Selectively targeting CD47 with bispecific antibody to efficiently eliminate mesothelin-positive solid tumors. Cancer Research. 79(13_Supplement). 546–546. 2 indexed citations

Moine, Valéry, Lucile Broyer, Xavier Chauchet, et al.. (2018). Abstract 2770: Dual-targeting mesothelin/CD47 bispecific antibodies for tumor-directed blockade of CD47 in solid cancer. Cancer Research. 78(13_Supplement). 2770–2770. 1 indexed citations

Ferlin, Walter, Vanessa Buatois, Krzysztof Masternak, et al.. (2018). Remodeling tumor-associated macrophages with a CD47xMesothelin bispecific antibody for efficient elimination of solid tumor cells.. Journal of Clinical Oncology. 36(15_suppl). e15126–e15126. 3 indexed citations

Hatterer, Eric, Leticia Barba, Nelly Noraz, et al.. (2018). Co-engaging CD47 and CD19 with a bispecific antibody abrogates B-cell receptor/CD19 association leading to impaired B-cell proliferation. mAbs. 11(2). 322–334. 31 indexed citations

Hatterer, Eric, Limin Shang, Pierre Simonet, et al.. (2016). A specific anti-citrullinated protein antibody profile identifies a group of rheumatoid arthritis patients with a toll-like receptor 4-mediated disease. Arthritis Research & Therapy. 18(1). 224–224. 29 indexed citations

10.

Hatterer, Eric, Suzanne Herren, Irene Di Ceglie, et al.. (2016). Spatiotemporal expression of endogenous TLR4 ligands leads to inflammation and bone erosion in mouse collagen‐induced arthritis. European Journal of Immunology. 46(11). 2629–2638. 19 indexed citations

11.

Shang, Limin, G Lapeyre, Eric Hatterer, et al.. (2015). AB0451 NI-0101, a Monoclonal Antibody Targeting Toll Like Receptor 4 (TLR4) Being Developed for Rheumatoid Arthritis (RA) Treatment with a Potential for Personalized Medicine. Annals of the Rheumatic Diseases. 74. 1046–1046. 17 indexed citations

12.

Hardy, Ian R., Nadia Anceriz, François Rousseau, et al.. (2014). Anti-CD79 Antibody Induces B Cell Anergy That Protects against Autoimmunity. The Journal of Immunology. 192(4). 1641–1650. 32 indexed citations

13.

Hatterer, Eric, Bruno Daubeuf, Laura Cons, et al.. (2013). Characterization of a surrogate murine antibody to model anti-human CD3 therapies. mAbs. 5(4). 555–564. 7 indexed citations

14.

Hatterer, Eric, Céline Lamacchia, Jean‐Marc Waldburger, et al.. (2012). Long‐term amelioration of established collagen‐induced arthritis achieved with short‐term therapy combining anti‐CD3 and anti–tumor necrosis factor treatments. Arthritis & Rheumatism. 64(10). 3189–3198. 10 indexed citations

15.

Hatterer, Eric, Naura Chounlamountri, Chantal Watrin, et al.. (2011). Syk kinase is phosphorylated in specific areas of the developing nervous system. Neuroscience Research. 70(2). 172–182. 8 indexed citations

16.

Lissilaa, Rami, Vanessa Buatois, Giovanni Magistrelli, et al.. (2010). Although IL-6 Trans-Signaling Is Sufficient To Drive Local Immune Responses, Classical IL-6 Signaling Is Obligate for the Induction of T Cell-Mediated Autoimmunity. The Journal of Immunology. 185(9). 5512–5521. 49 indexed citations

17.

Hatterer, Eric, Monique Touret, Marie‐Françoise Belin, Jérôme Honnorat, & Serge Nataf. (2008). Cerebrospinal Fluid Dendritic Cells Infiltrate the Brain Parenchyma and Target the Cervical Lymph Nodes under Neuroinflammatory Conditions. PLoS ONE. 3(10). e3321–e3321. 66 indexed citations

18.

Palazuelos, Javier, Nathalie Davoust, Boris Julien, et al.. (2008). The CB2 Cannabinoid Receptor Controls Myeloid Progenitor Trafficking. Journal of Biological Chemistry. 283(19). 13320–13329. 139 indexed citations

19.

Nataf, Serge, Nathalie Strazielle, Eric Hatterer, et al.. (2006). Rat choroid plexuses contain myeloid progenitors capable of differentiation toward macrophage or dendritic cell phenotypes. Glia. 54(3). 160–171. 31 indexed citations

20.

Davoust, Nathalie, Carine Vuaillat, Gaëlle Cavillon, et al.. (2006). Bone marrow CD34+/B220+ progenitors target the inflamed brain and display in vitro differentiation potential toward microglia. The FASEB Journal. 20(12). 2081–2092. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact